1. Home
  2. BHVN vs HIMX Comparison

BHVN vs HIMX Comparison

Compare BHVN & HIMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • HIMX
  • Stock Information
  • Founded
  • BHVN 2013
  • HIMX 2001
  • Country
  • BHVN United States
  • HIMX Taiwan
  • Employees
  • BHVN N/A
  • HIMX N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • HIMX Semiconductors
  • Sector
  • BHVN Health Care
  • HIMX Technology
  • Exchange
  • BHVN Nasdaq
  • HIMX Nasdaq
  • Market Cap
  • BHVN 1.7B
  • HIMX 1.5B
  • IPO Year
  • BHVN 2017
  • HIMX 2006
  • Fundamental
  • Price
  • BHVN $15.63
  • HIMX $9.01
  • Analyst Decision
  • BHVN Strong Buy
  • HIMX Buy
  • Analyst Count
  • BHVN 14
  • HIMX 1
  • Target Price
  • BHVN $49.23
  • HIMX $15.00
  • AVG Volume (30 Days)
  • BHVN 2.4M
  • HIMX 959.9K
  • Earning Date
  • BHVN 11-11-2025
  • HIMX 11-06-2025
  • Dividend Yield
  • BHVN N/A
  • HIMX 4.10%
  • EPS Growth
  • BHVN N/A
  • HIMX N/A
  • EPS
  • BHVN N/A
  • HIMX 0.42
  • Revenue
  • BHVN N/A
  • HIMX $889,561,000.00
  • Revenue This Year
  • BHVN N/A
  • HIMX N/A
  • Revenue Next Year
  • BHVN $2,195.07
  • HIMX $16.64
  • P/E Ratio
  • BHVN N/A
  • HIMX $21.18
  • Revenue Growth
  • BHVN N/A
  • HIMX N/A
  • 52 Week Low
  • BHVN $12.79
  • HIMX $5.12
  • 52 Week High
  • BHVN $55.70
  • HIMX $13.91
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 51.87
  • HIMX 60.22
  • Support Level
  • BHVN $14.32
  • HIMX $8.55
  • Resistance Level
  • BHVN $16.24
  • HIMX $9.31
  • Average True Range (ATR)
  • BHVN 0.82
  • HIMX 0.29
  • MACD
  • BHVN 0.11
  • HIMX 0.04
  • Stochastic Oscillator
  • BHVN 60.92
  • HIMX 69.36

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

Share on Social Networks: